Rabeprazole Sodium

CAS 117976-90-6 20 FDA-DMF suppliersSmall Molecule

Overview

Rabeprazole Sodium is a proton pump inhibitor that suppresses gastric acid secretion by specific inhibition of the H+/K+-ATPase enzyme system at the secretory surface of the gastric parietal cell. It is widely used in the treatment of gastroesophageal reflux disease (GERD), duodenal ulcers and Zollinger-Ellison syndrome.

API suppliers (21)

Suppliers of Rabeprazole Sodium backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • APITORIA PHARMA PRIVATE LTDIndia1 active DMF
  • APITORIA PHARMA PRIVATE LTDIndia1 active DMF
  • SYN-TECH CHEM AND PHARM CO LTD1 active DMF
  • Macleods Pharmaceuticals Ltd.India1 active DMF
  • APITORIA PHARMA PRIVATE LTDIndia1 active DMF
  • APITORIA PHARMA PRIVATE LTDIndia1 active DMF
  • APITORIA PHARMA PRIVATE LTDIndia1 active DMF
  • SYN-TECH CHEM AND PHARM CO LTD1 active DMF
  • MOEHS IBERICA SLSpain1 active DMF
  • Orchid Pharma LimitedIndia1 active DMF
  • Cadila Pharmaceuticals LimitedIndia
  • MYLAN LABORATORIES LTD
  • Alembic Pharmaceuticals LimitedIndia
  • UQUIFA MEXICO SA DE CV
  • NOSCH LABS PRIVATE LTD
  • Hetero Drugs LimitedIndia
  • Sun Pharmaceutical Industries LimitedIndia
  • SHANGHAI SINE PHARMACEUTICAL LABORATORIES CO LTD
  • Cipla USA, Inc.USA
  • Cadila Healthcare LimitedIndia
  • SINTENOVO SA DE CV

Therapeutic areas

Gastroenterology

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.